E. Wierzchosławska

The effect of different segmentation methods on primary tumour metabolic volume assessed in 18F-FDG-PET/CT in patients with cervical cancer, for radiotherapy planning

P. Cegła, E. Burchardt, E. Wierzchosławska, 2019, Contemporary oncology.

Metabolic activity in bone metastases of breast and prostate 18 cancer were similar as studied by F-FDG PET / CT . The 99 m role

R. Czepczyński, E. Wierzchosławska, W. Cholewiński, 2017 .

Comparison of 18F-fluoroethylo-L-thyrosine PET/CT and MR in the diagnosis of primary brain tumors referred to radiation therapy

P. Cegła, E. Wierzchosławska, W. Cholewiński, 2019, Nuclear medicine review. Central & Eastern Europe.

Impact of the COVID-19 Pandemic on Breast Cancer Stage at Diagnosis in a Regional Cancer Center in Poland between 2019 and 2021

W. Kycler, M. Trojanowski, M. Litwiniuk, 2022, Journal of personalized medicine.

Detection of the Prostate Cancer Bone Metastases: Is It Feasible to Compare 18F-fluorocholine PET/CT, 18F-fluorodeoxyglucose PET/CT and 99mTc-methyl Diphosphonate Bone Scintigraphy?

R. Czepczyński, E. Wierzchosławska, W. Cholewiński, 2018, Urology journal.

Atypical spleen tuberculosis in a melanoma patient accidentally detected during a 18F-FDG PET/CT study: Case report.

A. Spychała, A. Marszałek, P. Cegła, 2017, Molecular and clinical oncology.